Oragenics (OGEN) - P/S ratio

P/S ratio as of November 2024 (TTM): N/A

According to Oragenics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.27. At the end of 2024 the company had a P/S ratio of N/A.

P/S ratio history for Oragenics from 2006 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	N/A
2023	N/A
2022	N/A
2021	N/A
2020	N/A
2019	N/A
2018	N/A
2017	N/A
2016	N/A	-100%
2015	99.0	189.04%
2014	34.2	-65.05%
2013	98.0	80.51%
2012	54.3	1237.76%
2011	4.06	-68.74%
2010	13.0	-73.85%
2009	49.6	12.37%
2008	44.2	-48.8%
2007	86.3	-23.64%
2006	113

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
OPKO Health OPK	1.45	N/A	🇺🇸 USA
Nature's Sunshine Products NATR	0.6244	N/A	🇺🇸 USA
USANA USNA	0.8766	N/A	🇺🇸 USA
SIGA Technologies SIGA	3.13	N/A	🇺🇸 USA
Lannett Company LCI	0.0238	N/A	🇺🇸 USA
Johnson & Johnson JNJ	4.27	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Oragenics (OGEN)

P/S ratio as of November 2024 (TTM): N/A